|
DLEU1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.351800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.100400E-01 |
| Normal-vs-Stage2 |
1.080360E-02 |
| Normal-vs-Stage3 |
4.446200E-01 |
| Normal-vs-Stage4 |
4.970000E-01 |
| Stage1-vs-Stage2 |
3.094300E-02 |
| Stage1-vs-Stage3 |
6.367900E-02 |
| Stage1-vs-Stage4 |
1.240950E-01 |
| Stage2-vs-Stage3 |
3.543200E-03 |
| Stage2-vs-Stage4 |
5.099600E-03 |
| Stage3-vs-Stage4 |
9.718000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.673200E-01 |
| Normal-vs-AfricanAmerican |
8.245400E-01 |
| Normal-vs-Asian |
3.151200E-01 |
| Caucasian-vs-AfricanAmerican |
8.905000E-01 |
| Caucasian-vs-Asian |
1.864380E-01 |
| AfricanAmerican-vs-Asian |
3.740600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.330600E-01 |
| Normal-vs-Female |
1.936020E-01 |
| Male-vs-Female |
1.903990E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.007000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.355000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.097000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.322300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.310400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.181000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.474420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.390200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.695800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.119500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.615000E-03 |
| Classical-VS-Follicular |
3.26829999730549E-08 |
| Classical-VS-Other |
6.394000E-01 |
| Classical-VS-Normal |
6.218800E-01 |
| Tall-VS-Follicular |
1.47030054797881E-10 |
| Tall-VS-Other |
3.315800E-01 |
| Tall-VS-Normal |
9.842600E-03 |
| Follicular-VS-Other |
1.543800E-01 |
| Follicular-VS-Normal |
1.11329999996634E-06 |
| Other-VS-Normal |
8.151800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.994490E-02 |
| Normal-vs-N1 |
1.355840E-01 |
| N0-vs-N1 |
3.172800E-04 |
|
|
